Utilizing Technology to Enhance the Ecological Validity of Cognitive and Functional Assessments in Schizophrenia: An

William P Horan1,2, Raeanne C Moore3, Heather G Belanger4,5

  • 1Karuna Therapeutics, A Bristol Myers Squibb Company, Boston, MA, USA.

Schizophrenia Bulletin Open
|December 16, 2024
PubMed